These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 22880134
1. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells. Takaku M, Tomita S, Kurobe H, Kihira Y, Morimoto A, Higashida M, Ikeda Y, Ushiyama A, Hashimoto I, Nakanishi H, Tamaki T. PLoS One; 2012; 7(8):e42964. PubMed ID: 22880134 [Abstract] [Full Text] [Related]
2. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair. Ghadge SK, Messner M, Van Pham T, Doppelhammer M, Petry A, Görlach A, Husse B, Franz WM, Zaruba MM. J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361 [Abstract] [Full Text] [Related]
3. Inhibition of Prolyl Hydroxylase Attenuates Fas Ligand-Induced Apoptosis and Lung Injury in Mice. Nagamine Y, Tojo K, Yazawa T, Takaki S, Baba Y, Goto T, Kurahashi K. Am J Respir Cell Mol Biol; 2016 Dec; 55(6):878-888. PubMed ID: 27494234 [Abstract] [Full Text] [Related]
4. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis. Peng J, Lai ZG, Fang ZL, Xing S, Hui K, Hao C, Jin Q, Qi Z, Shen WJ, Dong QN, Bing ZH, Fu DL. PLoS One; 2014 Dec; 9(11):e112744. PubMed ID: 25394221 [Abstract] [Full Text] [Related]
5. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats. Liu XB, Wang JA, Ji XY, Yu SP, Wei L. Stem Cell Res Ther; 2014 Sep 25; 5(5):111. PubMed ID: 25257482 [Abstract] [Full Text] [Related]
8. 3D-printed dimethyloxallyl glycine delivery scaffolds to improve angiogenesis and osteogenesis. Min Z, Shichang Z, Chen X, Yufang Z, Changqing Z. Biomater Sci; 2015 Aug 25; 3(8):1236-44. PubMed ID: 26222039 [Abstract] [Full Text] [Related]
9. Perioperative Treatment with a Prolyl Hydroxylase Inhibitor Reduces Necrosis in a Rat Ischemic Skin Flap Model. Sergesketter AR, Cason RW, Ibrahim MM, Lane WO, Lubkin DT, Hollenbeck ST, Brown DA. Plast Reconstr Surg; 2019 Apr 25; 143(4):769e-779e. PubMed ID: 30921127 [Abstract] [Full Text] [Related]
11. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Kim YC, Ahn KS, Chen CY, Kim SH. Biol Pharm Bull; 2011 Apr 25; 34(6):850-5. PubMed ID: 21628883 [Abstract] [Full Text] [Related]
12. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury. Barnucz E, Veres G, Hegedűs P, Klein S, Zöller R, Radovits T, Korkmaz S, Horkay F, Merkely B, Karck M, Szabó G. J Pharmacol Exp Ther; 2013 Apr 25; 345(1):25-31. PubMed ID: 23388095 [Abstract] [Full Text] [Related]
15. Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential. Ding H, Gao YS, Wang Y, Hu C, Sun Y, Zhang C. Stem Cells Dev; 2014 May 01; 23(9):990-1000. PubMed ID: 24328551 [Abstract] [Full Text] [Related]
20. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression. Sun Y, Li QF, Zhang Y, Hu R, Jiang H. Cell Physiol Biochem; 2013 May 01; 31(4-5):579-91. PubMed ID: 23635649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]